Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Fosamprenavir calcium

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Fosamprenavir calcium used for?
The FDA-approved label (Fosamprenavir Calcium, Sun Pharmaceutical Industries, Inc., June 30, 2026) says: “Fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The following points should be considered when initiating therapy with fosamprenavir calcium tablets plus ritonavir in protease inhibitor-experienced patients …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Fosamprenavir calcium have a boxed warning?
No. None of the 2 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Fosamprenavir calcium?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Fosamprenavir calcium been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Fosamprenavir calcium?
2 companies list prescription products of Fosamprenavir calcium in the FDA NDC Directory, including Sun Pharmaceutical Industries, Inc. and Mylan Pharmaceuticals Inc..

What Fosamprenavir calcium is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The following points should be considered when initiating therapy with fosamprenavir calcium tablets plus ritonavir in protease inhibitor-experienced patients …

— FDA label: Fosamprenavir Calcium, Sun Pharmaceutical Industries, Inc., effective June 30, 2026. Read the full label on DailyMed →

The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 2 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsTablet, coated · Tablet, film coated
RouteOral
Prescription products2 in the FDA NDC Directory

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.

Generic approvals (2)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)402109
SPL set ID of the quoted label5cd1eead-9fc1-426c-bee8-214ffa7d9dc1
FDA labels (SPL)2
FDA applications2 ANDA
Active ingredients (FDA)FOSAMPRENAVIR

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Fosamprenavir Calcium, Sun Pharmaceutical Industries, Inc., effective June 30, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers